
In the BASKET-SMALL 2 randomized controlled trial, researchers compared the effect of a drug-coated balloon (DCB) against drug-eluting stents (DES) in patients with small coronary artery disease, either with or without high-bleeding risk (HBR), undergoing percutaneous coronary intervention. According to the article in Circulation: Cardiovascular Interventions, “DCBs were similarly safe and effective as current-generation DES in the treatment of coronary arteries <3 mm, regardless of bleeding risk.”
DCBs in Small Coronary Artery Disease Treatment
The study’s lead author, Bruno Scheller, wrote that these findings were based on a subgroup analysis of a 758 small coronary artery disease cohort from a multicenter, randomized, noninferiority trial undergoing percutaneous coronary intervention with DCB (n = 382) or second-generation DES (n = 376). Of the enrolled patients, 155 (20%) had HBR.